Gilead Palo Alto, Inc. develops and commercializes small molecule drugs for the treatment of cardiovascular diseases. It develops advances in molecular biology and genetics to identify mechanisms of cardiovascular diseases and targets for drug discovery. The company offers Ranexa (ranolazine extended-release tablets), which is used for the treatment of chronic angina; and Lexiscan (regadenoson) injection for use as a pharmacologic stress agent in radionuclide myocardial perfusion imaging (MPI). Its products under clinical development comprise Tecadenoson, which is in Phase III clinical trials product for the potential reduction of rapid heart rate during acute atrial arrhythmias, and in Phase II clinical trials for acute atrial fibrillation; Adentri, a Phase III clinical studies product for heart failure; CVT-6883, a Phase I clinical trial product to treat cardiopulmonary diseases; and CVT-3619, a Phase I clinical studies drug for diabetes/metabolic syndrome. The company s products under preclinical trials include Tecadenoson for atrial fibrillation; CVT-10,216 to treat alcohol addicted patients; Late I for the treatment of coronary artery disease; A2A antagonist for chemical dependence; ABCA1/ApoA-I to treat atherosclerosis; and Drug-Eluting Stent Program for the treatment of restenosis. The company has collaborative partnerships with Biogen Idec Inc.; Astellas Pharma, Inc.; Menarini Group; and Roche Palo Alto LLC. Gilead Palo Alto, Inc. was formerly known as CV Therapeutics, Inc. and changed its name to Gilead Palo Alto, Inc. in January 2009. The company was incorporated in 1990 and is based in Foster City, California. As of April 14, 2009, Gilead Palo Alto, Inc. operates as a subsidiary of Gilead Sciences Inc.Gilead Palo Alto, Inc. is a small pharmaceutical company based in California with only 50 employees and an annual revenue of $26.0M.
Gilead Palo Alto, Inc.'s mission statement
To advance the care of patients suffering from life-threatening diseases worldwide.
In demand companies are hiring! Let Zippia apply for you!
-
Gilead Palo Alto, Inc. employee reviews
Be the first to review!
Do you work at Gilead Palo Alto, Inc.?
Help job seekers learn about working at Gilead Palo Alto, Inc.
The key people at Gilead Palo Alto, Inc. is Daniel O’Day.
Key people
Daniel O’Day
Gilead Palo Alto, Inc. rankings
Gilead Palo Alto, Inc. is ranked #4 on the Best Pharmaceutical companies to work for in Foster City, CA list. Zippia's Best Places to Work lists provide unbiased, data-based evaluations of companies. Rankings are based on government and proprietary data on salaries, company financial health, and employee diversity.
Zippia gives an in-depth look into the details of Gilead Palo Alto, Inc., including salaries, political affiliations, employee data, and more, in order to inform job seekers about Gilead Palo Alto, Inc.. The employee data is based on information from people who have self-reported their past or current employments at Gilead Palo Alto, Inc.. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Gilead Palo Alto, Inc.. The data presented on this page does not represent the view of Gilead Palo Alto, Inc. and its employees or that of Zippia.
Gilead Palo Alto, Inc. may also be known as or be related to Gilead Palo Alto, Gilead Palo Alto Inc and Gilead Palo Alto, Inc.